ADSL and cancer: Additionally, several cationic, amphipathic AMPs arealso regarded as anticancer peptides due to their preferential cytolyticactivity on cancer cells, which possess more negatively charged cellmembrane than that of normal cells.46 Weenvision that our conjugate formulation could be tailored to moreselectively deliver these anticancer peptides to tumors for oncologyapplications.